EndoEvolution LLC
Automated suturing for minimally invasive surgery
This article was originally published in Start Up
Executive Summary
Despite great strides in minimally invasive surgery over the years, suturing continues to vex surgeons. That’s understandable, given the amount of hand-eye coordination required: surgeons hold two long instruments and watch a video screen from across the room while performing very intricate motions with their hands and fingers. EndoEvolution LLC has developed an automated suturing system that mimics the way surgeons manually suture. The Endo360° uses a traditional curved needle instead of a straight needle, and it drives the needle in the exact manner a surgeon would when suturing by hand: grabbing a needle from its tail, pushing the point of the needle through the tissue and picking up the point.
You may also be interested in...
Surgical Incision Closure: Start-Ups Address A Megatrend In Health Care
Medtech start-ups are working to develop next-generation incision closure devices that address the shortfalls of gold standard sutures and staples. We profile three hopefuls in this issue: EndoEvolution, ZipLine Medical and ZSX Medical.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.